DadFinStart your free week
DadFin › Stocks › Industrials › LMT

Lockheed Martin Corporation (LMT) stock score

Industrials · Aerospace & Defense · United States

$509.59 ▲ +0.33% today

51.9
Dad Score, out of 100
middling

Lockheed Martin Corporation (LMT) is a Aerospace & Defense company in the Industrials sector, listed in the United States. On DadFin's weekly run it scores 51.9 out of 100 on the Dad Score, a middling reading that places the business ahead of 52% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Industrials it ranks #371 of 704. Its strongest axes are valuation, quality and growth; its weakest are price action and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Strong
Growth
Above average
Price action
Weak
Risk
Average
Conviction
Weak
Liquidity
Strong
Macro
Below average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)18.6×
P/E (forward)15.4×
Dividend yield2.70%
Return on capital19.3%
Operating margin12.0%
Revenue growth (YoY)+5.6%
FCF yield5.2%
Net debt / EBITDA1.73×
Piotroski F-Score6 / 9
52-week change+0.8%
Market cap$116.6B
Next earningsOct 22, 2026

What subscribers see on LMT

Start your free weekSubscriber? Open the full research →

Aerospace & Defense peers

StockCompanyDad ScoreBandMarket cap
SPCXSpace Exploration Technologies Cor72.2good$2.09T
GEGE Aerospace32.9weak$321.2B
RTXRTX Corporation81.9good$248.9B
BAThe Boeing Company58.9middling$152.9B
HWMHowmet Aerospace Inc.75.6good$92.2B
GDGeneral Dynamics Corporation97.9strong$89.3B
NOCNorthrop Grumman Corporation54.5middling$67.9B
TDGTransDigm Group Incorporated75.8good$61.0B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.